Direct myocardial revascularization and angiogenesis - How many patients might be eligible?

American Journal of Cardiology

Volumn 84, Issue 5, 1999, Pages 598-600

  Mukherjee, Debabrata ^a   Bhatt, Deepak L ^a   Roe, Matthew T ^a   Patel, Vasant ^a   Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADULT; AGED; ANGIOGENESIS; BYPASS SURGERY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

EID: 0032842144     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00387-2     Document Type: Article

References (12)

1. Rosamond W.D., Chambless L.E., Folsom A.R., Cooper L.S., Conwill D.E., Clegg L., Wang C.H., Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 339:1998;861-867.
2. Hughes G.C., Donovan C.L., Lowe J.E., Landolfo K.P. Combined TMR and mitral valve replacement via left thoracotomy. Ann Thorac Surg. 65:1998;1141-1143.
3. Kim C.B., Kesten R., Javier M., Hayase M., Walton A.S., Billingham M.E., Kernoff R., Oesterle S.N. Percutaneous method of laser myocardial revascularization. Cathet Cardiovasc Diagn. 40:1997;223-228.
4. Go R.T., MacIntyre W.J., Cook S.A., Neumann D.R., Brunken R.C., Saha G., Underwood D.A., Marwick T.H., Chen E.Q., King J.L., Khandekar S. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission topographic imaging in patients with prior infarction and left ventricular dysfunction. J Nucl Cardiol. 3:1996;96-104.
5. Frazier OH, Cooley DA, Kadipasaoglu KA, Kindenmeir MH, Pehlivanaglu S, Kolff JW, Wilansky S, Moore WH. Myocardial revascularization with laser. Preliminary findings. Circulation 1995;92(suppl II):II-58-II-65.
6. Cooley D.A., Frazier O.H., Kadipasaoglu K.A., Kindenmeir M.H., Pehlivanaglu S., Kolff J.W., Wilansky S., Moore W.H. Transmyocardial laser revascularization clinical experience with twelve month follow-up . J Thorac Cardiovasc Surg. 111:1996;791-799.
7. Horvath K.A., Mannting F., Cummings N., Shernan S.K., Cohn L.H. Transmyocardial laser revascularization operative techniques and clinical results at two years . J Thorac Cardiovasc Surg. 111:1996;1047-1053.
8. Takashita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., Ferrara N., Symes J.F., Isner J.M. Therapeutic angiogenesis a single intraarterial bolus of vascular endothelial growth factor augments revascularization a rabbit ischemic hind limb model . J Clin Invest. 93:1994;662-670.
9. Isner J.M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., Symes J.F. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet. 348:1996;370-374.
10. Tsurumi Y, Kearney M, Chen D, Silver M, Takeshita S, Yang J, Symes JF, Isner JM. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997;96(suppl II):II-382-II-388.
11. Heart and Stroke Facts: 1996 Statistical Supplement. Dallas, TX: American Heart Association.
12. 1999 Heart and Stroke Statistical Update: 1998 Dallas, TX: American Heart Association.